Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CURTIS L JANSEN

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1447530597
CMS profile
201175
Location
MARBLE HILL, MO

General Payments · PY2018–2024

$1,283.94

  • Reported across 68 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$754.67

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $754.67 37

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $25.30 1
PY2019 $11.14 1
PY2020 $15.66 1
PY2021 $138.22 8
PY2022 $250.55 15
PY2023 $88.40 5
PY2024 $754.67 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $81.98 03/16/2024 Food and Beverage Undisputed 01/23/2026 1105585174 CMS
AstraZeneca Pharmaceuticals LP $13.50 04/08/2024 Food and Beverage Undisputed 01/23/2026 1105320647 CMS
AstraZeneca Pharmaceuticals LP $13.25 04/25/2024 Food and Beverage Undisputed 01/23/2026 1104435673 CMS
AstraZeneca Pharmaceuticals LP $15.21 06/18/2024 Food and Beverage Undisputed 01/23/2026 1105356128 CMS
AstraZeneca Pharmaceuticals LP $12.59 09/12/2024 Food and Beverage Undisputed 01/23/2026 1104596670 CMS
AstraZeneca Pharmaceuticals LP $15.11 10/08/2024 Food and Beverage Undisputed 01/23/2026 1104538084 CMS
AstraZeneca Pharmaceuticals LP $14.37 10/10/2024 Food and Beverage Undisputed 01/23/2026 1104652405 CMS
AstraZeneca Pharmaceuticals LP $14.74 11/16/2024 Food and Beverage Undisputed 01/23/2026 1104731891 CMS
Axsome Therapeutics, Inc. $21.94 05/07/2024 Food and Beverage Undisputed 01/23/2026 1148273385 CMS
Axsome Therapeutics, Inc. $24.47 08/12/2024 Food and Beverage Undisputed 01/23/2026 1148273387 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.67 04/10/2024 Food and Beverage Undisputed 01/23/2026 1118013649 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $18.27 10/04/2024 Food and Beverage Undisputed 01/23/2026 1118013647 CMS
Exact Sciences Corporation $24.16 08/08/2024 Food and Beverage Undisputed 01/23/2026 1114717424 CMS
Lilly USA, LLC $14.59 06/18/2024 Food and Beverage Undisputed 01/23/2026 1136125921 CMS
Lilly USA, LLC $21.08 09/02/2024 Food and Beverage Undisputed 01/23/2026 1136111428 CMS
Lundbeck LLC $22.44 03/06/2024 Food and Beverage Undisputed 01/23/2026 1145928818 CMS
Lundbeck LLC $16.20 04/30/2024 Food and Beverage Undisputed 01/23/2026 1145928820 CMS
Lundbeck LLC $27.49 07/03/2024 Food and Beverage Undisputed 01/23/2026 1145928822 CMS
Lundbeck LLC $22.19 09/04/2024 Food and Beverage Undisputed 01/23/2026 1145928824 CMS
Novartis Pharmaceuticals Corporation $15.41 02/08/2024 Food and Beverage Undisputed 01/23/2026 1087127952 CMS
Novartis Pharmaceuticals Corporation $15.16 03/22/2024 Food and Beverage Undisputed 01/23/2026 1087127954 CMS
Novartis Pharmaceuticals Corporation $17.40 06/13/2024 Food and Beverage Undisputed 01/23/2026 1087127958 CMS
Novartis Pharmaceuticals Corporation $13.60 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087127960 CMS
Novartis Pharmaceuticals Corporation $13.66 10/17/2024 Food and Beverage Undisputed 01/23/2026 1087127962 CMS
Novo Nordisk Inc $17.44 03/21/2024 Food and Beverage Undisputed 01/23/2026 1096931449 CMS
Novo Nordisk Inc $14.31 04/09/2024 Food and Beverage Undisputed 01/23/2026 1096689246 CMS
Novo Nordisk Inc $20.50 05/16/2024 Food and Beverage Undisputed 01/23/2026 1096920242 CMS
Novo Nordisk Inc $22.16 07/17/2024 Food and Beverage Undisputed 01/23/2026 1097046693 CMS
Novo Nordisk Inc $19.84 09/19/2024 Food and Beverage Undisputed 01/23/2026 1097837626 CMS
Novo Nordisk Inc $24.51 09/25/2024 Food and Beverage Undisputed 01/23/2026 1097732749 CMS
Novo Nordisk Inc $14.39 10/16/2024 Food and Beverage Undisputed 01/23/2026 1096745709 CMS
Novo Nordisk Inc $34.97 10/31/2024 Food and Beverage Undisputed 01/23/2026 1097186796 CMS
Novo Nordisk Inc $5.20 12/11/2024 Food and Beverage Undisputed 01/23/2026 1096710370 CMS
Otsuka America Pharmaceutical, Inc. $19.76 06/05/2024 Food and Beverage Undisputed 01/23/2026 1118914919 CMS
Otsuka America Pharmaceutical, Inc. $25.20 10/16/2024 Food and Beverage Undisputed 01/23/2026 1118914921 CMS
Phathom Pharmaceuticals, Inc. $21.08 09/11/2024 Food and Beverage Undisputed 01/23/2026 1151076594 CMS
Phathom Pharmaceuticals, Inc. $18.83 10/14/2024 Food and Beverage Undisputed 01/23/2026 1151076596 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.